Atherosclerosis III: Management
Psychosis: Goals of Pharmacotherapy
Inflammatory Bowel Disease IV: Pharmacological Management
Peptic Ulcer Disease IV: Management
Peripheral Artery Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 23, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Aida J Al-Kudwah1, Steven R Feldman
1Department of Dermatology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1071, USA.
Psoriasis affects 2-3% of people, impacting quality of life. Effective treatment requires addressing clinical, psychological, and social factors, with newer biologic agents offering improved efficacy and safety.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: